Diagnostics
9 recent notes from companies in this sector. 2 companies tracked.
Metropolis Q1 revenue up ~16% but growth slows from Q4's 23.6%
Wellness and specialty segments drive volumes; EBITDA margins improve YoY and stay stable sequentially. Full results await board approval.
Krsnaa cuts Rajasthan revenue guidance by half, delays rollout
The flagship PPP project now targets ₹100-150 crore for FY27, down from ₹200-250 crore, as the network launch slips to Q2.
Krsnaa Diagnostics releases Q4 and FY26 management commentary
The company issued a press release alongside its previously disclosed annual results, focusing on retail growth and cash flow.
Krsnaa Diagnostics reports FY26 results with no new surprises
The company confirmed FY26 profit figures previously disclosed to the market. Revenue growth remains modest, and the tax demand remains a known issue.
Krsnaa Diagnostics posts FY26 profit of ₹102.7 cr but the numbers are stale
The audited results disclose no new information beyond what the exchange already has. A ₹62.7 crore tax demand remains unresolved.
Krsnaa's profit is up 24% but it's hiding a ₹63 crore tax demand.
Standalone net profit rose to ₹102.7 crore, but ₹25.9 crore of that was a one-off investment revaluation. Auditors also flagged a ₹62.7 crore tax claim.
Star Imaging reports stagnant FY26 revenue of ₹5,002 lakhs
The diagnostic firm posted a modest profit increase while top-line growth remained effectively flat for the fiscal year.
Suraksha Diagnostic's revenue grows 20%. Profit doesn't follow.
Revenue hit ₹300.68 cr in FY26, up 20.7%. Profit after tax grew just 1.9%. The earnings lag is the story.
Krsnaa Diagnostics gets ₹11.3 cr tax notice, says it will contest
The demand, for 2018-19 and 2019-20, is only 0.6% of market cap. The company is confident of defending on merits.